Article
Analyses of disease-related GNPTAB mutations define a novel GlcNAc-1-phosphotransferase interaction domain and an alternative site-1 protease cleavage site.
Human molecular genetics - 15 Jun 2015
Velho Renata Voltolini, De Pace Raffaella, Klünder Sarah, Sperb-Ludwig Fernanda, Lourenço Charles Marques, Schwartz Ida V D, Braulke Thomas, Pohl Sandra
Abstract excerpt
Mucolipidosis II (MLII) and III alpha/beta are autosomal-recessive diseases of childhood caused by mutations in GNPTAB encoding the α/β-subunit precursor protein of the GlcNAc-1-phosphotransferase complex. This enzyme modifies lysosomal hydrolases with mannose 6-phosphate targeting signals. Upon arrival in the Golgi apparatus, the newly synthesized α/β-subunit precursor is catalytically activated by site-1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
